PL384446A1 - Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2,4-tiazolidynodionu z kwasem malonowym i sposób jej wytwarzania - Google Patents

Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2,4-tiazolidynodionu z kwasem malonowym i sposób jej wytwarzania

Info

Publication number
PL384446A1
PL384446A1 PL384446A PL38444608A PL384446A1 PL 384446 A1 PL384446 A1 PL 384446A1 PL 384446 A PL384446 A PL 384446A PL 38444608 A PL38444608 A PL 38444608A PL 384446 A1 PL384446 A1 PL 384446A1
Authority
PL
Poland
Prior art keywords
methyl
tiazolidynodion
pyridinamino
ethoxy
phenyl
Prior art date
Application number
PL384446A
Other languages
English (en)
Polish (pl)
Inventor
Michał Chodyński
Wioleta Maruszak
Andrzej Kutner
Magdalena Glice
Anita Pietraszek
Katarzyna Korczak
Hanna Fitak
Marek Kubiszewski
Original Assignee
Adamed Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adamed Spółka Z Ograniczoną Odpowiedzialnością filed Critical Adamed Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL384446A priority Critical patent/PL384446A1/pl
Priority to PCT/PL2009/000015 priority patent/WO2009102226A1/fr
Publication of PL384446A1 publication Critical patent/PL384446A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL384446A 2008-02-12 2008-02-12 Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2,4-tiazolidynodionu z kwasem malonowym i sposób jej wytwarzania PL384446A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL384446A PL384446A1 (pl) 2008-02-12 2008-02-12 Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2,4-tiazolidynodionu z kwasem malonowym i sposób jej wytwarzania
PCT/PL2009/000015 WO2009102226A1 (fr) 2008-02-12 2009-02-11 Sel d'acide malonique de la 5-[[4-[2-(méthyl-2-pyridinylamino)éthoxy]phényl]méthyl]-2,4-thiazolidinedione

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL384446A PL384446A1 (pl) 2008-02-12 2008-02-12 Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2,4-tiazolidynodionu z kwasem malonowym i sposób jej wytwarzania

Publications (1)

Publication Number Publication Date
PL384446A1 true PL384446A1 (pl) 2009-08-17

Family

ID=40810587

Family Applications (1)

Application Number Title Priority Date Filing Date
PL384446A PL384446A1 (pl) 2008-02-12 2008-02-12 Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2,4-tiazolidynodionu z kwasem malonowym i sposób jej wytwarzania

Country Status (2)

Country Link
PL (1) PL384446A1 (fr)
WO (1) WO2009102226A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011107494A1 (fr) 2010-03-03 2011-09-09 Sanofi Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
WO2013037390A1 (fr) 2011-09-12 2013-03-21 Sanofi Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
EP2760862B1 (fr) 2011-09-27 2015-10-21 Sanofi Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique utilisés comme inhibiteurs de kinase
WO2013068486A1 (fr) 2011-11-08 2013-05-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Méthodes pour le diagnostic et le traitement de l'infertilité masculine
CN109053718B (zh) * 2018-08-09 2022-06-03 天津理工大学 一种罗格列酮糖精盐及其制备方法
CN109053717B (zh) * 2018-08-09 2022-05-31 天津理工大学 一种罗格列酮龙胆酸盐及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (de) * 1987-09-04 2000-05-11 Beecham Group Plc Substituierte Thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
AU2002352479A1 (en) * 2001-12-20 2003-07-09 Smithkline Beecham Plc 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitus
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel

Also Published As

Publication number Publication date
WO2009102226A1 (fr) 2009-08-20

Similar Documents

Publication Publication Date Title
PL384446A1 (pl) Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2,4-tiazolidynodionu z kwasem malonowym i sposób jej wytwarzania
IL295518B1 (en) Heterocyclic compounds used as pdk1 inhibitors
IL216349A (en) Annals 4– (1-carboxy-ethylcarbamoyl) –4– (5– [1,12] diethylan-3-ram-pentanoylamino) -butyric acid and preparations containing them
IL223002A0 (en) Crystalline form of 4- [5 - [3 -chloro-5 - (trifluoromethyl) phenyl] -4, 5 - dihydro - 5 - (trifluoromethyl) -3 - isoxazolyl] -n- [2-0x0-2- [ ( 2, 2, 2 - trifluoroethyl) amino] ethyl] -1- naphthalenecarboxamide
IL207854A0 (en) Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4]oxadiazol-5-yl]-3-nit robenzene-1,2-diol
ZA201103033B (en) Thioamide compounds, method of making and method of using thereof
IL247136B (en) Compounds for reducing uric acid and their uses
ZA201303253B (en) Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-yl-thio)acetic acid and uses thereof
ME02307B (me) Kristalni (r)-(e)-2-(4-(2-(5-(1-(3,5-diklorpiridin-4-il)etoksi)-1h-indazol- 3-il)vinil)-1h-pirazol-1-il)etanol i njegova upotreba kao inhibitora fgfr
HK1162516A1 (en) (4-[4-[5-(substituted amino)-pyridin-2-yl]phenyl]-cyclohexyl)-acetic acid derivatives as dgat inhibitors
IL220211A (en) Process for Preparation of Acid History 1 - (Alkyl / Phenyl / Pyrid-2-Il) -5-Carboxylic Pyrazole and Intermediates Obtained in This Process
IL212070A (en) Phenyl and pyridyl history of 7-piperidinoalkyl-4,3-dihydroquinolone
HK1164856A1 (en) Polymorphic forms of 3-(1-3-[5-(1-methyl-piperidin-4ylmethoxy)-pyrimidin- 2-yl]-benzyl-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof 3-(1-3-[5-(1---4-)--2-]--6--16--- 3-)-
EP2381772A4 (fr) Procédés et intermédiaires de synthèse de dérivés d'acides bêta-aminés n-acylés-4-aryle
HK1189591A1 (en) Hydrochloride salt of 5-r3-f3-tivdroxyphenoxy)azetidi-1-v-5-methyl-2 2- diphenylhexanamide 5-[3-(3-)-1-]-5--22-
IL208834A0 (en) Method for the production of halogen-substituted 2-(aminomethylidene)-3- oxobutyric acid esters
BRPI1011931A2 (pt) trans-4[[(5s)-5-[[[3,5-bis(trifluorometil)fenil]metil] de ácido(2-metil-2h-tetrazol-5-il)amino]-2,3,4,5-tetra-hidro-7,9-dimetil-1h-1-benzazepin-1-il]metil]-ciclo-hexanocarboxílico
GB2465180B (en) Method of Contained Transfer
IL207431A0 (en) New process for the preparation of cyclohexanecarboxylic acid derivatives
EP2304506A4 (fr) Toner possédant de multiples points d inflexion sur la courbe du module de conservation par rapport à la température et procédé de préparation associé
EP2305673A4 (fr) Cristal de composé de thiazolidinedione, et son procédé de production
CY2200159T2 (el) 2-ν-{5-[[4-[2-μεθυλ-2-πυριδινυλαμινο)αιθοξυ]φαινυλ]μεθυλ]-2-4-θειαζολιδινοδιονο} βουτανιοδιοϊκο οξυ, μεθοδοι παρασκευης και συνθεσεις με μηλεϊνικη ροζιγλιταζονη
IL213599A0 (en) Improved biocatalysts for manufacturing duloxetine alcohol
PL385697A1 (pl) Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2, 4-tiazolidynodionu z kwasem 1, 5-naftalenodisulfonowym i sposób jej wytwarzania
PL385222A1 (pl) Nowe sole N-[2-(alkoksykarbonylo)etylo]-N-metylo-1-amino-1-dezoksy-D-glucitoli i sposób ich wytwarzania

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)